IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 123 filers reported holding IMMUNOCORE HLDGS PLC in Q2 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $130,825,939 | -13.4% | 2,520,731 | 0.0% | 0.75% | -13.8% |
| Q2 2023 | $151,143,031 | +21.3% | 2,520,731 | 0.0% | 0.88% | +29.1% |
| Q1 2023 | $124,624,941 | -13.4% | 2,520,731 | 0.0% | 0.68% | -21.5% |
| Q4 2022 | $143,858,118 | +21.6% | 2,520,731 | 0.0% | 0.86% | +11.5% |
| Q3 2022 | $118,323,000 | +25.8% | 2,520,731 | +0.0% | 0.78% | +45.1% |
| Q2 2022 | $94,048,000 | +24.8% | 2,520,730 | 0.0% | 0.53% | +23.3% |
| Q1 2022 | $75,370,000 | -12.7% | 2,520,730 | 0.0% | 0.43% | +3.1% |
| Q4 2021 | $86,310,000 | -7.6% | 2,520,730 | 0.0% | 0.42% | +2.4% |
| Q3 2021 | $93,443,000 | -5.1% | 2,520,730 | 0.0% | 0.41% | -5.1% |
| Q2 2021 | $98,435,000 | -8.3% | 2,520,730 | 0.0% | 0.43% | -7.1% |
| Q1 2021 | $107,307,000 | – | 2,520,730 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $34,592,303 | 27.53% |
| RTW INVESTMENTS, LP | 6,029,633 | $361,536,795 | 6.88% |
| Paradigm Biocapital Advisors LP | 1,270,124 | $76,156,635 | 5.88% |
| Rock Springs Capital Management LP | 3,028,410 | $181,583,464 | 4.32% |
| Logos Global Management LP | 500,000 | $29,980,000 | 4.08% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $24,319,776 | 3.58% |
| GREAT POINT PARTNERS LLC | 297,082 | $17,813,037 | 3.49% |
| Eschler Asset Management LLP | 34,000 | $2,038,640 | 2.89% |
| COWEN AND COMPANY, LLC | 460,036 | $27,583,758 | 2.29% |
| HighVista Strategies LLC | 44,094 | $2,643,876 | 1.21% |